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Force Enhancement Without Changes in Cross-Bridge Turnover Kinetics:
The Effect of EMD 57033
Theresia Kraft and B. Brenner
Department of Clinical Physiology, Medical School Hannover, D-30625 Hannover, Germany
ABSTRACT The thiadiazinon derivative EMD 57033 has been found previously in cardiac muscle to increase isometric force
generation without a proportional increase in fiber ATPase, thus causing a reduction in tension cost. To analyze the
mechanism by which EMD 57033 affects the contractile system, we studied its effects on isometric force, isometric fiber
ATPase, the rate constant of force redevelopment (kredev), active fiber stiffness, and its effect on Fo, which is the force
contribution of a cross-bridge in the force-generating states. We used chemically skinned fibers of the rabbit psoas muscle.
It was found that with 50,M EMD 57033, isometric force increases by more than 50%, whereas kredev, active stiffness, and
isometric fiber ATPase increase by at most 10%. The results show that EMD 57033 causes no changes in cross-bridge
turnover kinetics and no changes in active fiber stiffness that would result in a large enough increase in occupancy of the
force-generating states to account for the increase in active force. However, plots of force versus length change recorded
during stretches and releases (T plots) indicate that in the presence of EMD 57033 the yo value (x axis intercept) for the
cross-bridges becomes more negative while its absolute value increases. This might suggest a larger cross-bridge strain as
the basis for increased active force. Analysis of T plots with and without EMD 57033 shows that the increase in cross-bridge
strain is not due to a redistribution of cross-bridges among different force-generating states favoring states of larger strain.
Instead, it reflects an increased cross-bridge strain in the main force-generating state. The direct effect of EMD 57033 on the
force contribution of cross-bridges in the force-generating states represents an alternative mechanism for a positive inotropic
intervention.
INTRODUCTION
Modulation of force generation is a major mechanism in
adaptation of muscle tissue to changes in loading condi-
tions. Different ways of such modulation have previously
been demonstrated, e.g.: 1) a higher cytosolic calcium con-
centration in response to the action potential ([calcium]i
amplitude modulation; Ruegg, 1986), and 2) a higher cal-
cium sensitivity of the contractile system itself. If the in-
crease in force is mediated through a higher calcium sensi-
tivity of the contractile system instead of a higher
intracellular calcium concentration, at least two different
mechanisms could lead to an increase in contractility (Bren-
ner, 1993). First, increased force can be the result of
changes in calcium binding to TnC or in subsequent steps in
the activation of the thin filament. In this case, at submaxi-
mum calcium concentrations, force increases for a given
calcium concentration, resulting in a shift of the force/pCa
relation to the left without affecting the force level at
maximum activation. The second possible mechanism of
increasing the calcium responsiveness of the contractile
system results from the rate modulation concept for calcium
regulation of muscle contraction (Brenner, 1988). That is,
calcium modulates cross-bridge turnover kinetics, or more
specifically, it increases the rate constant for the transition
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of cross-bridges from non-force-generating states to force-
generating states. It was shown that interventions that affect
turnover kinetics can cause not only an increase in active
force at submaximum and maximum calcium concentra-
tions, but also a shift of the force/pCa relation to lower
calcium concentrations without changes in the calcium af-
finity of the regulatory proteins.
Here we present evidence for another mechanism that
causes higher force output without changes in sarcoplasmic
calcium concentration. It appears that the higher force out-
put is due to an increase in force generated by individual
cross-bridges. This mechanism was found when studying
the effects of the thiadiazinon-derivative 5-(1-(3,4-dime-
thoxybenzoyl)- 1,2,3,4-tetrahydrochinolin-6-yl)-6- methyl-
3,6-dihydro-2H-1,3,4-thiadiazin-2-on (EMD 53998), a race-
mic equimolar mixture of two enantiomers. In several
studies the effects of the mixture of the two enantiomeres,
EMD 53998, were tested, and others were carried out with
the (+) enantiomer, EMD 57033 (Gambassi et al., 1993;
Lues et al., 1993; White et al., 1993; Solaro et al., 1993).
Analyzing the effects of EMD 53998 on different intact
preparations of cardiac muscle, several investigators (Fer-
roni et al., 1991; Beier et al., 1991) found that EMD 53998
increases the amplitude of twitches without increasing the
accompanying calcium transient. Therefore it was con-
cluded that the positive inotropic effect of the substance
might be related to an augmented sensitivity of the myo-
filaments to calcium. Furthermore, in intact cardiac muscle,
simultaneous measurements of tension and fluorescence
signals reflecting the intracellular calcium concentration
(Lee and Allen, 1991; Dobrunz et al., 1995) showed a
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leftward shift of the force/pCa relation with EMD 53998
and thus supported the idea of an increase in calcium
sensitivity of the thin filament. The same conclusion was
derived from studies with chemically skinned cardiac mus-
cle from different species (Beier et al., 1991; GroB et al.,
1993; Leijendekker and Herzig, 1992), which also showed a
shift of the force/pCa relation to the left. Measurements of
energy cost of twitch force in intact cardiac muscle (Grol3 et
al., 1993; Grandis et al., 1994) revealed a reduction in
energy cost with EMD 57033. A similar effect, but only at
submaximum calcium concentrations, was also observed in
skinned pig trabeculae with EMD 53998 (Leijendekker and
Herzig, 1992). Therefore EMD 57033 apparently exhibits a
positive inotropic effect without increasing the oxygen con-
sumption of the myocardium.
The mechanism by which EMD 57033 affects the con-
tractile and/or regulatory proteins of cardiac muscle, how-
ever, remained unclear. Enhancement of calcium binding to
TnC with EMD 57033 appeared unlikely, because EMD
53998 and EMD 57033 not only cause a leftward shift of the
force/pCa relation; they also increase the force at maximum
calcium concentrations and reduce the tension cost (Do-
brunz et al., 1995; Beier et al., 1991; Leijendekker and
Herzig, 1992; Grol3 et al., 1993). Both effects are unex-
pected for an increase in calcium binding to TnC. In agree-
ment with that, Solaro and co-workers (1993) found no
effect of EMD 57033 on calcium binding to TnC in skinned
heart muscle fibers. The increase in force at maximum
calcium concentration instead suggested that changes in
cross-bridge turnover kinetics or even another mechanism is
responsible for the effects of EMD 57033. The observed
shift of the force/pCa relation, the increase in force at
maximum calcium concentrations, and the lower tension
cost with EMD 57033 could in principle be attributed to a
change in gapp (rate constant for the transition of the cross-
bridges from the force-generating states to the non-force-
generating states) possibly associated with changes in fapp
(rate constant for the transition of the cross-bridges into the
force-generating states).
The goal of the present study was to determine the
mechanism by which EMD 57033 affects force and tension
cost of skeletal muscle fibers. Because most of the previous
work with EMD 57033 and with the racemic mixture EMD
53998 was done on cardiac muscle preparations, a prereq-
uisite of the present study was to demonstrate that EMD
57033 has comparable effects on single skinned skeletal
muscle fibers from rabbit psoas. For the present study we
focused our attention on maximum activation only.
To our surprise, measurements of isometric force and
tension cost, together with additional measurements of ac-
tive turnover kinetics, isometric stiffness, and cross-bridge
strain, revealed that at least in maximally activated skeletal
muscle fibers the increase in force with reduced tension cost
in the presence of EMD 57033 cannot be accounted for by
changes in cross-bridge cycling kinetics. Instead, the in-
crease in force appears to result from a higher force gener-
Brenner, 1991). Specifically, it appears that EMD 57033
increases the force generated in at least the main force-
generating state, possibly in all of the force-generating
cross-bridge states. Such an increased force generation rep-
resents a further mechanism for a positive inotropic inter-
vention at reduced tension cost. A preliminary account of
this work has been presented earlier (Kraft et al., 1994).
MATERIALS AND METHODS
Fiber preparation
Single chemically skinned fibers from rabbit psoas muscle were isolated
according to a method described earlier (Yu and Brenner, 1989). The
skinning procedure, the storage of isolated muscle fibers, and the mounting
of the fibers in the mechanical setup were reported in detail by Kraft et al.
(1995).
Solutions
All chemicals were obtained from Sigma (Munich, Germany) except where
noted. The composition of the skinning solution including protease inhib-
itors was the same as described recently (Kraft et al., 1995).
All solutions, except where noted, were adjusted to an ionic strength of
170 mM by adding potassium propionate.
EMD 57033 solution
EMD 57033 was kindly provided by E. Merck (Darmstadt, Germany).
EMD 57033 was dissolved in propylene glycol (1,2-propanediol), and from
this stock solution (2 mM) the appropriate amounts for the different EMD
57033 concentrations were added to the respective solutions. In control
experiments we examined the effects of propylene glycol alone (no EMD
57033) to correct for possible propylene glycol effects. We found that the
highest propylene glycol concentration used (2.5%) increases isometric
force by 10% at most. All data shown in this study were corrected for
effects of the respective propylene glycol concentrations.
Preactivating and activating solution
Preactivating and activating solution consisted of imidazole (10 mM),
MgCl2 (2 mM), MgATP (1 mM), dithiothreitol (2 mM), caffeine (10 mM),
creatine phosphate (10 mM), 500 units of creatine phosphokinase/ml, and
EGTA (3 mM) or CaEGTA (3 mM), respectively.
To reduce contaminating phosphate, preactivating and activating solu-
tions also contained 20 mM sucrose and 10 units/ml sucrose phosphorylase
(Boehringer, Mannheim, Germany) and were kept at room temperature
(20°C) for 10 min before use (modified from Pate and Cooke, 1989).
To obtain different calcium concentrations ranging from pCa 7 to pCa
4.5, preactivating and activating solutions were added together in different
proportions. The preactivating and activating solutions for varying calcium
concentrations at 5C and at 15°C (Fig. 4 b) contained mM EGTA and
1 mM CaEGTA, respectively, and no sucrose or sucrose phosphorylase.
Relaxing solution with MgATP
Relaxing solution with MgATP consisted of 10 mM imidazole, 2 mM
ated by the cross-bridges in the force-generating states (FO;
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Solution for measurements of isometric fiber ATPase
under preactivating and activating conditions
The solution for measurements of isometric fiber ATPase under preacti-
vating and activating conditions consisted of 20 mM imidazole, 2 mM
MgCl2, 3 mM EGTA or CaEGTA respectively, 5 mM MgATP, 10 mM
caffeine, 0.25 mM ApNA, 5 mM NaN3, 50 units lactate-dehydrogenase/ml,
250 units pyruvate-kinase/ml, 2 mM phosphoenol-pyruvate, and about 0.2
mM NADH. Phosphoenol-pyruvate and pyruvate kinase are part of a
coupled enzyme system that makes it possible to follow the hydrolysis of
MgATP by the fibers. Pyruvate, which is one product of the rephospho-
rylation, was converted into lactate by lactate dehydrogenase, accompanied
by oxidation ofNADH to NAD+. Production of ADP was then detected as
a decrease in absorbance at 360 nm.
Solutions with MgATPyS
Solutions with MgATPyS at low Ca21 consisted of 10 mM imidazole, 2
mM MgCl2, 3 mM EGTA, and 10mM MgATPyS (Boehringer Mannheim;
purified by ion exchange chromatography as previously described; Kraft et
al., 1992), 1 mM dithiothreitol, 0.2 mM Ap5A, 0.5 units hexokinase/ml,
and 200 mM glucose. For high calcium concentrations, EGTA was re-
placed by 1 mM CaEGTA.
All solutions were adjusted to pH 7.0 at the experimental temperature of
5°C or 1°C, respectively.
Experimental protocol
Isometric force was measured during a quick release of the activated fiber
when force briefly dropped from its isometric value to zero. The rate
constant of force redevelopment was determined after a short period of
lightly loaded shortening and a subsequent restretch of the fiber to its
original sarcomere length (Brenner and Eisenberg, 1986).
Isometric fiber ATPase was determined in a circulating system that
included the muscle chamber and a flow cell in a fixed-wavelength monitor
(UV-M HI; Pharmacia LKB, Sweden), where changes in absorption at 360
nm due to the decrease of NADH concentration were measured. For each
condition, the steady-state ATPase activity was recorded for at least 5 min,
and the observed slopes were normalized with respect to the slope recorded
without EMD 57033 to obtain the relative ATPase activities. To test
whether the fiber ATPase activity measured under the different conditions
could have been limited by the activity of the coupled enzyme system, we
added 10 ,uM ADP to the activating solution after removal of the fiber. The
observed slope of absorbance change in response to the ADP jump was at
least 10 times larger than during the previous activation. Thus the system
was certainly not limited during fiber activation.
The muscle chamber in the circulating system was designed such that,
simultaneously with ATPase measurements, isometric force and the rate
constant of force redevelopment could be recorded with sarcomere length
feedback (Brenner and Eisenberg, 1986). In addition, it was possible to
monitor the structural integrity of the fiber by light microscopy.
Fiber stiffness was measured by applying ramp-shaped stretches to one
end of the fibers. Apparent fiber stiffness was defined as the ratio of force
increment over filament sliding when filament sliding had reached 2
nm/half-sarcomere (chord stiffness). Stretch velocity could be varied from
10-' to 5 X 103 (nm/half sarcomere)/s to obtain stiffness-speed relations
(Brenner et al., 1986).
The unloaded shortening velocity (v..) of the fibers was determined
using the slack test (Hill, 1970). During isometric steady-state contraction,
rapid length releases (5 ms) of different amplitudes were applied to slacken
the fiber. The time was determined from the beginning of the release until
the fiber had taken up the slack and started to redevelop force. This time
was plotted as a function of the amplitude of the applied length step. Vma,
was then determined as the initial slope of this plot (cf. Fig. 1 c).
Plots of force versus sarcomere length change ("T plots"; Kuhn et al.,
1979) were obtained by imposing stretches and releases on the fibers
during isometric steady-state contraction (cf. Fig. 2; Brenner, 1991).
Relation between cross-bridge turnover kinetics
and the measured parameters
Assuming that under the present experimental conditions such as low Pi
concentration, the reverse rate constants (i.e., fapp and g- ,) can be ne-
glected, isometric force, ATPase activity, and tension cost are expected to
depend on the following parameters (Huxley, 1957; Brenner, 1988):
Isometric force F = n X Fo X fapp /(app + gapp)
Isometric fiber ATPase A = n X b X fapp
X gapp/(tapp + gapp),
(1)
(2)
whereby fapp/(fapp + gapp) represents the occupancy of force-generating
states (fapp = rate constant for the transition into the strongly bound
force-generating states, gapp = rate constant for the transition of the
cross-bridges back into the weakly bound non-force-generating states; n =
number of active cross-bridges per half-sarcomere; Fo = force contribution
by a strongly attached cross-bridge; b = number of half-sarcomeres). At
low Pi concentrations, when the reverse reactions that depend on rebinding
of Pi can be neglected (fapp---* 0), the rate constant for force redevelopment
(k,edev) iS
(3)kredev = fapp + gapp.
Finally, tension cost is the ratio of ATPase/force:
ATPase/force = (b X gapp)/Fo. (4)
Note: 1) Isometric force depends on both the rate constants for cross-bridge
cycling (fapp and gapp) and (Fo), the force generated by an individual
cross-bridge in the force-generating state(s). 2) Tension cost depends on Fo
as well as gapp.
RESULTS
The effects of EMD 57033 on isometric force,
kre,iv9 fiber ATPase, and vma, in skinned single
fibers from rabbit psoas muscle
In most studies concerning the effects ofEMD 57033 on the
contractile system, intact and skinned preparations from
heart muscle were used. For comparison of our results with
data from other authors, we first tested whether EMD 57033
has similar effects on skeletal muscle fibers. We determined
isometric force, the maximum unloaded shortening velocity
(vmax), ATPase activity, and tension cost of maximally
calcium-activated skinned fibers of rabbit psoas at different
EMD 57033 concentrations (Fig. 1).
Fig. 1 a shows that the addition of up to 50 ,uM EMD
57033 causes an increase in active force of 50-60%. Si-
multaneous measurements of ATPase activity (Fig. 1 a)
show that with 10 ,uM EMD 57033 the ATP turnover is
about 10% higher than in the absence of EMD 57033, but
there is no further increase in ATPase activity with higher
EMD 57033 concentrations, in contrast to the large further
increase in force generation. Consequently, the ratio of
ATPase over force, i.e., the tension cost, decreases by 25%
in the presence of 50 AM EMD 57033 (Fig. 1 b). In Fig. 1
c the results from slack test measurements with (30 AM)
and without EMD 57033 are shown. Data recorded from
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FIGURE 1 (A) Isometric force (A) and isometric fiber ATPase (A) of fully calcium-activated skeletal muscle fibers in the presence and absence ofEMD
57033. The values are normalized to force or ATPase, respectively, without EMD 57033, n = 3-12 fibers, ± SEM. (B) The ratio of ATPase over force
of fully calcium-activated skeletal muscle fibers as a function of EMD 57033 concentration. The values are normalized to ATPase/force without EMD
57033, n = 3-9 fibers, ± SEM. (C) Unloaded shortening velocity (Vmax) of one representative muscle fiber in the absence (x) and in the presence (x) of
30,tM EMD 57033 determined by the slack test. Fiber length is plotted as a function of time required to take up the slack (data from one fiber). The average
of the initial slope (vmax) of 3 fibers is 1.08 ± 0.16 (ttm/HS)s-' without and 1.10 ± 0.1 (pkm/HS)s-' with 50 ,uM EMD 57033. (D) The rate constant for
force redevelopment (kredev) at maximum calcium activation versus EMD 57033 concentration. The values are normalized to kredev without EMD 57033,
n = 3-12 fibers, ± SEM.
three different fibers show that maximum unloaded short-
ening velocity (Vmax) is 1.08 0.16 (,um/HS)s without
and 1.10 0.10 (tkm/HS)s with EMD 57033. In the
concept of Huxley (1957), vmax is mainly determined by g2,
the rate constant for detachment when cross-bridges become
unstrained during isotonic shortening. Thus our result indi-
cates that EMD 57033 has no effect on g2. Altogether, the
effects of EMD 57033 on force, ATPase, tension cost, and
vmax of fast skeletal muscle fibers are very similar to those
found earlier for intact and skinned cardiac muscle.
The main purpose of the present study was, however, to
determine the mechanism by which EMD 57033 increases
force generation. According to Eq. 1 isometric force gener-
ation is, besides other parameters, controlled by the occu-
pancy of force-generating states (fapp/fapp + gapp) and thus
is sensitive to changes in turnover kinetics (fapp and/or gapp)
of the cross-bridges. To obtain indications for possible
changes in turnover kinetics with EMD 57033, we measured
kredev, the rate constant of force redevelopment after a short
period of unloaded isotonic shortening and a quick restretch
to isometric sarcomere length. kredev represents fapp + gapp
+ fa-pp + g-p; under isometric conditions and low Pi,
however, it is essentially fapp + gapp (Eq. 3) (Brenner,
1988).
Fig. 1 d demonstrates that kredev is essentially the same
over the whole range ofEMD 57033 concentrations. Only a
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FIGURE 2 Force versus change in sarcomere length recorded during
ramp-shaped stretches and releases (T plots). The two records with (50
jxM) and without EMD 57033 were taken from one representative fiber.
Speed of the applied length change was 0.5-1.2 X 103 (nm/HS)/s. The
broken lines represent the initial slope of plots recorded from the same
fiber under identical conditions but at a speed for stretch and release of
3-4 X 103 (nm/HS)/s. The average value for yo at this speed of stretch for
5 fibers is 3.6 ± 0.72 nm/HS without and 7.38 ± 1.1 nm/HS with EMD
57033. (Inset) Schematic representation of two attached force generating
states (A and B) with different strain. The dotted line represents the
expected shape of the T plot if in the presence of EMD 57033 more
cross-bridges would occupy state B (cf. inset), i.e., a state of larger strain
(for details see text).
small increase is detectable at 10 ,uM EMD 57033, which,
however, is still within experimental error. This suggests
that the increase in isometric force with EMD 57033 appar-
ently is not due to a significant change in one of the rate
constants (fapp or gapp), which determine kredev under these
low-Pi conditions. The data, however, cannot exclude si-
multaneous changes in fapp and gapp that cancel out each
other.
As will be discussed below, essentially no change in
kredevw together with no further change in ATPase at EMD
57033 concentrations above 10 ,uM, indicates that the ob-
served increase in force does not result from changes infapp
and/or gapp. Therefore, additional measurements were nec-
essary to clarify the mechanism by which EMD 57033
increases isometric force generation.
Effects of EMD 57033 on T plots recorded during
isometric steady-state contraction
Inspection of Eq. 1 shows that, alternatively, isometric
force could be increased by an EMD 57033-induced in-
crease in Fo, the average force generated by a cross-bridge
in the force-generating states. Such an increase in Fo could,
in principle, result from 1) a different distribution of cross-
bridges among force-generating states (e.g., states A and B
ofthe inset in Fig. 2) favoring the state of larger strain (i.e.,
higher force contribution), like state B in the inset of Fig. 2.
Alternatively, 2) higher force with EMD 57033 could result
from an increase in average strain in the force-generating
states (i.e., A and B).
Such a redistribution and change in strain, however, can
be detected in plots of force versus length change recorded
during stretches and releases (T plots; Kuhn et al., 1979;
Brenner, 1991). Fig. 2 shows a parallel shift of the T plot in
the presence of 50 ,uM EMD 57033 to higher isometric
force. The deviation from a straight line (i.e., from the initial
slope) upon releases indicates the transition of cross-bridges
into subsequent force-generating states (e.g., from state A to
state B in the inset of Fig. 2; cf. Huxley and Simmons, 1971;
Ford et al., 1977; Brenner, 1991) and can be observed when
the releases are slow enough to allow this transition. There-
fore, the original records in Fig. 2 were obtained with
releases and stretches of 0.5-1.2 X 103 (nm/HS)/s.
If an increase in occupancy of state B would be respon-
sible for the observed increase in force with EMD 57033, a
redistribution from state B to state A should be seen upon
stretches in the presence ofEMD 57033. This redistribution
would show up in the T plots as indicated by the dotted line
in Fig. 2 (Brenner, 1991). The experimental data (Fig. 2),
however, give no indication of such a backward reaction in
the presence of EMD 57033, not only at the stretch veloc-
ities shown in Fig. 2, but over a range of stretch velocities
(from 10 (nm/HS)/s to 4 X 103 (nm/HS)/s; data not shown).
This suggests that under isometric conditions, not only in
the absence ofEMD 57033 but also with EMD 57033, there
is no significant occupancy of state B and thus for both
conditions isometric force is generated essentially by cross-
bridges in state A (cf. Brenner, 1991).
Such larger isometric force without changes in occupancy
of the force-generating states or distribution between differ-
ent force-generating states could be due to a larger distor-
tion of the cross-bridges in the presence of EMD. This is
expected to show up as a larger x axis intercept (yo) of T
plots recorded with the fastest releases possible. For such
fast releases no transition into subsequent states occurs, and
the intercept with the abscissa (yo, yo + EMD 57033),
obtained when extrapolating the initial parts of these plots,
might be taken as a measure for average cross-bridge strain
under isometric conditions. The broken lines in Fig. 2
represent the initial slope of the T plots obtained with the
same fiber at the highest possible speeds of stretches and
releases (3-4 X 103 (nm/HS)/s). We found that in the
absence of EMD 57033 yo is about 3.6 ± 0.72 nmIHS,
whereas with 50 ,uM EMD 57033 it reaches about 7.38 ±
1.1 nm/HS (n = 5 fibers).
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Active and relaxed fiber stiffness with EMD 57033
With faster releases, the initial slope of the curve, i.e., the
observed stiffness, increases (Fig. 2) because less detach-
ment and reattachment occurs during the stiffness measure-
ment. As indicated by the dashed lines, yo does not increase
by exactly the same amount as active force, i.e., the slope of
the dashed line with EMD 57033 is slightly but not signif-
icantly larger. This indicates a somewhat higher fiber stiff-
ness in the presence of EMD 57033 and is shown in detail
in Fig. 3 a. At 10 ,uM EMD 57033 stiffness increases by
about 10%, and there is no further increase at higher EMD
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57033 concentrations, although active force increases by
another 40-50% (Fig. 1 a). The increase in active stiffness
by 10%, which is similar to the increase in ATPase activity
(Fig. 1 a) may, however, reflect a slightly higher (10%)
occupancy of the force-generating cross-bridge states due to
small changes in cross-bridge turnover kinetics leading to
a small but statistically insignificant increase in kredev
(Fig. 1 d).
To test whether the slightly higher active stiffness could
indicate an increased actin affinity of weakly (and/or
strongly) binding cross-bridges with EMD 57033, we also
studied the effect of EMD 57033 on weakly binding cross-
bridges. Because we had found that some but small active
force is generated under relaxing conditions with EMD
57033, we had to use the nonhydrolyzable ATP analog
ATP,yS to avoid active cross-bridge cycling while measur-
ing relaxed fiber stiffness with EMD 57033. Cross-bridges
with ATPyS as nucleotide were previously shown to rep-
resent weakly binding cross-bridge states, even in the pres-
ence of calcium (Kraft et al., 1992). Fig. 3 b shows that 30
,uM EMD 57033 causes an increase in relaxed fiber stiff-
ness with ATPyS both in the presence and in the absence of
calcium. These data are consistent with a somewhat in-
creased actin affinity of cross-bridges in the presence of
EMD 57033.
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FIGURE 3 (A) Active fiber stiffness at maximum calcium activation as
a function of EMD 57033 concentration. The values are normalized to
stiffness without EMD 57033, n = 6 fibers, + SEM, and the speed of the
applied length change was 3-4 X 103 (nm/HS)/s). (B) Relaxed fiber
stiffness as a function of speed of stretch in the presence of 10 mM
MgATPyS at pCa 9.0 and pCa 4.5 in the absence of EMD 57033 and with
30 ,uM EMD 57033. The values are normalized to stiffness (average)
observed in the presence of calcium and EMD 57033 at the fastest stretch
velocities. Data are from one representative fiber. 0, No EMD 57033, pCa
9.0; *, 30 ,uM EMD 57033, pCa 9.0; D, no EMD 57033, pCa 4.5; *, 30
,iM EMD 57033, pCa 4.5. Ionic strength = 75 mM; T = 1°C. Note that the
conditions here are somewhat different from all of the other experiments
presented in this paper. (Lines fitted by eye.)
DISCUSSION
In the present study we provide evidence that the increase in
force of fully calcium-activated skeletal muscle fibers with
EMD 57033 is due to an increase in force contribution of a
cross-bridge in the force-generating states (FO). This in-
crease appears to result from an increased average cross-
bridge strain in each of the force-generating states. Mea-
surements of turnover kinetics, fiber ATPase, and active
fiber stiffness support the idea that cross-bridge cycling
kinetics (i.e., fapp and/or gapp) are not affected by EMD
57033. From the equations that describe isometric force
(Eq. 1) and tension cost (Eq. 4), it is obvious that an increase
in Fo can account not only for the increase in isometric
force, but also for the decrease in ATPase/force without
changes in cross-bridge cycling kinetics (fapp, gapp)- In
general, the effects of EMD 57033 on skinned skeletal
muscle fibers, like the increase in force and the reduced
tension cost, are very similar to the effects of EMD 57033
on skinned (Beier et al., 1991; GroB et al., 1993; Leijendek-
ker and Herzig, 1992; Simnett et al., 1994) and intact
cardiac muscle preparations (GroB and Daut, 1991; Do-
brunz et al., 1995).
Effects on cross-bridge cycling kinetics
If the increase in force with EMD 57033 were due to
changes in cross-bridge cycling kinetics resulting in a
higher occupancy of force-generating cross-bridge states,
i.e. a redistribution between non-force-generating and force-
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generating states, these changes should 1) change the frac-
tion of strongly bound cross-bridges and thus lead to
changes in fiber stiffness and 2) appear as corresponding
changes in kredev and/or isometric fiber ATPase. Under the
conditions used here (minimized Pi concentration and max-
imum calcium activation), kredev is essentially the sum of
fapp and gapp. Based on Eq. 1, changes in one of the two rate
constants, fapp and gapp, or simultaneous changes infapp and
gapp could affect the isometric force level.
To account for a 50% increase in force (at 50 ,iM EMD
57033), either 1) gapp had to decrease by about 75% (no
change in fapp) or 2) fapp had to increase more than fourfold
(no change in gapp). Such changes in gapp would lead to a
decrease in the ratio ATPase/force by 80% and a decrease in
kredev by about 35%. A more than fourfold increase infapp
would result in an almost fourfold increase in kredev. The
results presented in this study (Fig. 1), however, indicate
that ATPase/force decreases at most by 25%, and kredev does
not change significantly. Therefore both results are clearly
inconsistent with the behavior expected when EMD 57033
effects would be the result of changes in fapp or gapp.
3) Another possibility is that both fapp and gapp change
such that kredev remains constant, while force increases more
than 50%. This would require that without EMD 57033,
fapp < 1.5 s-1, gapp . 2.5 s- 1, and the resulting fraction of
force-generating cross-bridges would be '0.375. In the
presence of EMD 57033, the rate constants would have to
change such that fapp(+EMD 57033) 2.25 s-1,
gapp(+EMD 57033) 1.75 s-1. However, not only would
such values forfapp and gapp without EMD 57033 be incon-
sistent with experimental data (fapp = 3-4 s-5, gapp = 1
s- l, occupancy of the strongly binding cross-bridge states at
maximum activation 0.6-0.75; Brenner, 1988), but fiber
stiffness should also increase by 25% to 50%, depending on
the contribution of filament compliance.
Note that if the occupancy of the force-generating cross-
bridge states in the absence of EMD 57033 is already
0.6-0.75, an increase in force by 50-60% due to changes
in the occupancy of force-generating states becomes rather
unlikely.
The small change in active fiber stiffness, which is in
clear contrast to the much larger increase in active force,
supports this conclusion (Fig. 3 a). A nearly parallel in-
crease in active stiffness and isometric force would be
expected if the increase in force with EMD 57033 were due
to an increase in the occupancy of the force-generating
cross-bridge states, provided that stiffness is measured un-
der conditions where non-force-generating (weakly bound)
cross-bridges make little or no contribution to the observed
fiber stiffness.
The findings that cross-bridge kinetics seem to be unaf-
fected by EMD 57033 is further supported by the observa-
tion that EMD 57033 has no effect on Vmax, the maximum
unloaded shortening velocity. Vma, is mainly determined by
g2, the rate constant for cross-bridge detachment during
isotonic shortening (Huxley, 1957). This observation is
effect on the time course of cell shortening in intact cardiac
muscle (Gambassi et al., 1993; Solaro et al., 1993). The fact
that EMD 57033 increases isometric force generation but
does not impair shortening velocity might be important for
the possible role of EMD 57033 as positive inotropic agent.
A possible mechanism
As already pointed out, the increase in isometric force upon
the addition of EMD 57033 seems to be due to changes in
average force generated by the individual cross-bridges in
the force-generating states (FO). It was also shown that the
cross-bridges presumably generate the higher force because
the strain or distortion in each of the force-generating states
(states A and B in the inset of Fig. 2) increases with EMD
57033, whereas no redistribution among the force-generat-
ing states is seen that could result in any relevant increase in
isometric tension. Such an increase in strain shows up in T
plots as a larger yo value in the presence of EMD 57033.
However, the increase in yo with EMD 57033 could also
result from filament compliance dominating fiber stiffness
at such high force levels (Huxley, 1994; Wakabayashi,
1994). In this case, any change in force would be associated
with only little change in fiber stiffness. To distinguish
between the two possibilities we determined active force
and active stiffness, also at submaximum force levels
achieved by lowering the calcium concentration 1) in the
presence and absence of EMD 57033 and 2) at 50C and
150C. Both the addition of EMD 57033 or raising the
temperature to 150C result in a similar increase in active
force (Fig. 4, a and b). Reducing the calcium concentration
in both cases causes a decrease in active stiffness which,
however, is still nearly proportional to the decrease in active
force as seen at low temperature in the absence of EMD.
This suggests that the lack of an increase in active fiber
stiffness in proportion with force upon the addition of EMD
57033 at 5°C (or raising temperature to 15°C) is not due to
filament compliance dominating fiber stiffness, but rather
reflects an increase in average strain of the force-generating
cross-bridges. The observation that the two interventions,
raising temperature or the addition ofEMD 57033, show the
same effects on force and fiber stiffness makes it rather
unlikely that the observed behavior is mainly due to the
direct effects ofEMD 57033 or temperature on thin filament
compliance, except when both interventions, by coinci-
dence, would alter thin filament compliance to the same
extent.
The larger strain and thus the larger Fo with EMD 57033
might for example result from a tighter binding of these
cross-bridges. Some evidence for tighter binding can be
drawn from the effects of EMD 57033 on relaxed fiber
stiffness with ATPyS (Fig. 3 b), indicating a change in actin
binding kinetics, e.g., slower reversible dissociation with
EMD 57033. As a consequence of higher actin affinity,
cross-bridges could remain attached, even at higher strain
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FIGURE 4 Plots of active fiber stiffness versus isometric force recorded
at different calcium concentrations (pCa 7-4.5), (A) in the absence ofEMD
57033 (-) and in the presence of 50 AM EMD 57033 (b) at 50C (D1) and
at 15°C (A). Speed of stretch was about 4 X 103 (nm/HS)/s. (Lines
represent linear least-squares fits (a) and second-order polynomial fits (B)
to the data points.) The data in a and b show measurements of one
representative fiber each. The data of each fiber were normalized to the
average of all measurements made at pCa 4.5 in the absence ofEMD 57033
at 5°C. The data points clustered around 1.0 represent the individual
measurements at this condition. Note that for both interventions, the
presence of EMD 57033, as well as increased temperature, stiffness still
falls almost in proportion with tension, as it does at 50C and without EMD
57033. Thus at all force levels fiber stiffness apparently is not dominated
by filament compliance but is still sensitive to the fraction of force-
generating cross-bridges.
levels, resulting in the higher Fo. It should be noted that
such a mechanism does not necessarily result from binding
of EMD 57033 to myosin. Our data do not allow us to
determine the component of the actomyosin complex to
which EMD 57033 might bind.
Relation to other studies
In several previous studies, mechanisms other than an in-
crease in Fo have been proposed for the EMD 57033 effects.
From the observation that EMD 57033 causes a reduction in
tension cost and a shift of the force/pCa relation to the left
(GroB et al., 1993; Leijendekker and Herzig, 1992), it was
concluded that a reduction in gapp could be responsible for
the EMD 57033 effect. Such a conclusion can only be
drawn when changes in Fo that also affect tension cost can
be excluded.
On the other hand, Simnett et al. (1994) found no effect
of EMD 57033 on the relaxation rate of skinned skeletal
muscle. From that, and the assumption that Fo remains
constant, they speculated that gapp is not affected but that
EMD 57033 rather increases fapp. This would result in an
increase in kredev and would have had no effect on tension
cost (Eq. 4). The opposite, however, was found in our study.
Alternatively, an increase in Fo without changes in cross-
bridge cycling kinetics would also be compatible with no
effect of EMD 57033 on the relaxation rate.
Findings that EMD 53998 decreases the tension cost of
skinned cardiac muscle only at increased Pi concentrations
(Strauss et al., 1994) and that the Pi release step is acceler-
ated by EMD 53998 (Zhao and Kawai, 1995) led to the
conclusion that EMD 53998 antagonizes the effects of high
Pi concentrations on cross-bridges. This would favor force-
producing cross-bridge states in the presence of high Pi
concentrations and thus result in higher force levels. With
such a mechanism, however, EMD 57033 would only exert
an effect at high Pi concentrations. Although we cannot
exclude an additional effect ofEMD 57033 at high Pi levels,
our results are inconsistent with the concept that EMD
57033 only reverses Pi effects. We obtained the large in-
crease in isometric force already at very low Pi concentra-
tions, achieved by the presence of sucrose and sucrose
phosphorylase.
Several authors also observed a leftward shift of the
force/pCa relation in the presence of EMD 57033 (Beier et
al., 1991; GroB3 et al., 1993; Leijendekker and Herzig,
1992). Based on the present study, one possible explanation
for such a leftward shift could be the higher actin affinity of
the cross-bridges observed with EMD 57033. This could
result in more pronounced activating effects of strongly
attached cross-bridges on the thin filament at submaximum
calcium concentrations. It may even be responsible for the
activation of the thin filament at calcium concentrations
sufficiently low for full relaxation in the absence of EMD
57033 (unpublished results). Hence the shift of the force-
pCa relation by EMD 57033 could be due to enhanced
activation potential of strongly attached cross-bridges, re-
sulting in largerfapp at given nonsaturating calcium concen-
trations (i.e., the higher fapp at nonsaturating calcium con-
centrations would be an indirect effect of EMD 57033 via
an increase in actin affinity of strongly bound cross-
bridges). In agreement with that, studies on TnC-extracted
cardiac myofibrils showed that EMD 57033 activates the
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ATPase activity of these fibers but does not require TnC for
transmission of its effect (Solaro et al., 1993). Furthermore,
direct measurements of calcium binding to TnC in skinned
cardiac muscle (Solaro et al., 1993) showed that EMD
57033 has no effect on the calcium binding properties of
TnC.
However, it must be left to further experiments to clarify
whether and to what extent a higher activation potential of
strongly attached cross-bridges due to increased actin affin-
ity may be responsible for the leftward shift of the force/pCa
relation with EMD 57033 or whether additional effects are
present.
Side effects
The increase in resting tension in intact cardiac muscle (Lee
and Allen, 1991) and in diastolic pressure in isolated rat
hearts (Ferroni et al., 1991) with EMD 53998 could well be
due to the increased actin affinity of cross-bridges and
possible increased activation potential that would result in a
more pronounced turning on of the contractile system, even
at low calcium concentrations. An increased activation po-
tential of strongly attached cross-bridges might also be the
basis for a prolongation of the time course of the twitch with
EMD 57033 and EMD 53998 in intact heart muscle, which
was found by several investigators (Beier et al., 1991;
Ferroni et al., 1991; Lee and Allen, 1991; White et al., 1993;
Grol3 et al., 1993; Dobrunz et al., 1995).
CONCLUSION
The results presented here indicate that the EMD 57033
effects might represent a new mechanism for positive ino-
tropic agents that act through a direct effect on the force
generated by each cross-bridge. Further support for the
proposed mechanism through an increase in actin affinity
must be left to additional studies. Nevertheless, it appears
possible to directly affect the force contribution of a cross-
bridge, which provides an additional method of positive
inotropic intervention. Such a direct effect may have advan-
tages over positive inotropic compounds that act through an
increase in cytosolic calcium concentration and thus tend to
produce calcium overload of the myocardium.
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